Challenges

EXPERT will address several major challenges that have limited mRNA therapeutics from displaying their full potential:

• The ability to achieve functional target tissue delivery of mRNA by nanomedicine design
• The capability to circumvent adverse immune responses towards mRNA nanomedicines
• The scientific knowledge to achieve general applicability of an mRNA-based platform technology for various diseases and administration routes
• The know-how to accomplish quality control and overcome regulatory hurdles